Information Provided By:
Fly News Breaks for September 23, 2016
GSK
Sep 23, 2016 | 06:20 EDT
Piper Jaffray analyst Richard Purkiss started GlaxoSmithKline with an Overweight rating and GBP 20 price target. The company's growth is defensive and its risks are declining, Purkiss tells investors in a research note.
News For GSK From the Last 2 Days
There are no results for your query GSK